However the majority of the published circulating miRNA studies of cardiovascular pathologies and pathological models were focused on ischemic cardiomyopathies [19], [46], whereas the cMyBP-C related cardiomyopathy is not an ischemic heart disease, thus explaining a different dysregulated circulating miRNAs species. This evidence concerns the gene MYBPC3 and coronary artery disorder.